AI-generated summary
The authors review recent data on topical, systemic, light, and laser treatments for vitiligo, melasma, and postinflammatory hyperpigmentation. They report a lack of large, well-designed randomized controlled trials for these therapies, with options often drawn from smaller trials and case series. The authors describe the treatments as promising candidates for larger follow-up studies.
- Who or what was studied
- Patients with vitiligo, melasma, or postinflammatory hyperpigmentation
- Limits stated in the abstract
- The abstract notes a paucity of large-scale, well-designed randomized controlled trials and that treatment options rely on smaller trials and case series.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.